Irinotecan + Eltrombopag Olamine Interaction
Moderateinteraction on record
Description
BCRP substrate (active metabolite SN-38); monitor for excessive exposure and consider dose reduction if appropriate.
Mechanism
BCRP transporter inhibition
Source: NLP:eltrombopag olamine